哪吒机器人提醒：
提醒：The Lancet
【标题】[This Week in Medicine] February 11–17, 2012
【摘要】on jan 31, the us food and drug administration approved a new drug, ivacaftor, for the treatment of cystic fibrosis in patients aged 6 years or older with the g551d mutation in the cystic fibrosis transmembrane regulator (cftr) gene. it is the first drug that targets the defective cftr protein, the underlying cause of cystic fibrosis.... (02-10 08:38)
手机哪吒网 m.iNezha.com 有人网